GSE68230 ERK inhibition 1 v 2 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE68230_ERK inhibition_1_v_2_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE68230_ERK inhibition_1_v_2_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE68230_ERK inhibition_1_v_2_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE68230_ERK inhibition_1_v_2_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

ribosomal protein SA pseudogene 14

Gene

ribosomal protein L5 pseudogene 34

Gene

ribosomal protein L21 pseudogene 53

Gene

ribosomal protein S7 pseudogene 11

Gene

ribosomal protein L7 pseudogene 9

Gene

ribosomal protein L7a pseudogene 11

Gene

RPS3A pseudogene 26

Gene

ribosomal protein L21 pseudogene 120

Gene

ribosomal protein L7a pseudogene 30

Gene

glutathione S-transferase theta 2B

  • Gene

    ribosomal protein SA pseudogene 14


  • Gene

    ribosomal protein L5 pseudogene 34


  • Gene

    ribosomal protein L21 pseudogene 53


  • Gene

    ribosomal protein S7 pseudogene 11


  • Gene

    ribosomal protein L7 pseudogene 9


  • Gene

    ribosomal protein L7a pseudogene 11


  • Gene

    RPS3A pseudogene 26


  • Gene

    ribosomal protein L21 pseudogene 120


  • Gene

    ribosomal protein L7a pseudogene 30


  • Gene

    glutathione S-transferase theta 2B

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.